S3671

What happened: On January 15, 2026, Senator Steve Daines (R-MT) introduced the Increasing Investor Opportunities Act (S.3671). The bill amends the Investment Company Act of 1940 to prohibit the SEC from restricting closed-end funds from investing in private funds, and from restricting the listing of such closed-end fund securities on national securities exchanges. The bill has one cosponsor (Sen. Rounds) and has been referred to the Senate Committee on Banking, Housing, and Urban Affairs. It is at the earliest legislative stage. The money trail: This bill does not authorize or appropriate any federal funding. It is a deregulatory measure that removes SEC constraints on capital allocation. The economic effect is structural: it opens a new channel for closed-end funds (which can be sold to retail investors) to invest in private funds (private equity, private credit, hedge funds). This increases the total addressable market for private fund managers by allowing them to access retail capital through closed-end fund wrappers without SEC prohibition. The bill also mandates that national securities exchanges cannot be restricted by the SEC from listing these closed-end fund shares, which increases listing and trading revenue for exchanges. Structural winners: Primary beneficiaries are alternative asset managers $BX (Blackstone) and $KKR, as their private funds gain a new capital source from closed-end fund structures. $ICE, which owns the NYSE, is the most directly impacted exchange beneficiary due to NYSE's dominant position in closed-end fund listings. $CME may see indirect benefits from increased hedging activity by private funds but the link is weaker. Market data context: As of April 30, 2026, $BX trades at $122.93, down from a 52-week high of $190.09, with a 30-day change of +6.9% but a 7-day change of only +1.05%. $KKR trades at $102.80, up 11.14% over 30 days. $ICE trades at $160.15, up 1.82% over 30 days. The bill was introduced on January 15, 2026, over three months ago, and its early-stage status means any stock price movement attributable to this bill would have been discounted by January. The recent price trends for BX and KKR reflect broader market and sector movements, not specific bill momentum. Timeline: The bill is in the earliest stage — referred to committee with only one cosponsor and no scheduled hearings. Passage probability is low in the near term. The 119th Congress runs through January 2027. For the bill to advance, it must receive a hearing, markup, committee vote, floor vote in the Senate, companion legislation in the House (HR3383 is related but not identical), and presidential signature. This is a multi-year process at best.